LivaNova PLC Return on Equity

LivaNova PLC (LIVN) currently reports a ROE of 14.23%. That is below the Healthcare sector average of 20.77%. Use the charts on this page to explore LivaNova PLC's ROE history and peer comparisons.

LivaNova PLC's ROE of 14.23% is lower than the Healthcare sector average of 20.77%. That is roughly 31.5% below the sector mean. A reading lower peers can reflect different growth expectations, capital structure, or profitability — so it is worth checking the peer comparison chart before drawing conclusions.

There is no universal 'good' ROE, but LivaNova PLC's current 14.23% should be judged against Healthcare norms (sector average: 20.77%) and against LIVN's own history. Strong, stable readings often indicate durable competitive advantage; volatile or declining ones deserve a closer look at margins and capital efficiency.

Start with the current ROE of 14.23%, then check the historical chart for trend and the peer comparison chart for relative positioning. The Healthcare average is 20.77%. From there, open related valuation or income-statement pages for LivaNova PLC, and consider following LIVN for alerts when major investors trade the stock.

LivaNova PLC is classified in the Healthcare sector. On ROE, it currently shows 14.23% versus a sector average near 20.77%. Sector peers often share similar capital intensity and growth regimes, so relative rankings inside Healthcare are usually more informative than comparing LIVN with unrelated industries.